Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Takara Bio Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Takara Bio Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Takara Bio Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Takara Bio Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Takara Bio Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Takara Bio Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Rubicon Genomics Raises USD2 Million in Venture Financing 12
Partnerships 13
Rubicon Genomics Enters Into Licensing Agreement With University Of Michigan 13
WaferGen Bio-systems Enters into Distribution Agreement with Takara Bio 14
Takara Bio Enters into Agreement with Integrated DNA Technologies 15
WaferGen Biosystems Enters into Research Agreement with Women’s College Research Institute 16
Rubicon Genomics Enters Into Distribution Agreement With GenoMax Technologies For DNA Library Prep Kits 17
Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 18
WaferGen Biosystems Enters Into Co-Marketing Agreement With Qiagen 19
Takara Bio Enters Into Co-Marketing Agreement With Pathogenica For HAI Sequencing Service 20
WaferGen Biosystems Enters Into Agreement With Integrated DNA Technologies 21
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 22
Rubicon Genomics Enters Into Technology Integration Agreement With Kreatech Diagnostics 23
New England Biolabs Enters Into Co-Marketing Agreement With Rubicon Genomics 24
PerkinElmer Enters Into Distribution Agreement With Rubicon Genomics 25
Takara Bio Forms Joint Venture With DSS Imagetech 26
Takara Bio Enters Into Licensing Agreement With InVivoScribe Technologies For FLT3-ITD 27
Eppendorf Enters Into Licensing Agreement With Takara Bio 28
Equity Offering 29
WaferGen Bio-systems Raises USD17.25 Million in Public Offering of Common Stock 29
Takara Bio Raises USD112 Million in Public Offering Of Common Stock 30
Acquisition 31
Takara Bio Acquires WaferGen Bio-Systems 31
Takara Bio Acquires Rubicon Genomics for USD75 Million 33
Takara Bio Inc – Key Competitors 34
Takara Bio Inc – Key Employees 35
Takara Bio Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Joint Venture 37
Recent Developments 38
Financial Announcements 38
Nov 28, 2017: Takara Bio: Consolidated Financial Statements for the Second Quarter Ended September 30, 2017 38
May 09, 2016: Takara Bio: Consolidated Financial Statements for the Year Ended March 31 40
Product News 43
Feb 29, 2016: Clontech Laboratories Releases TaKaRa Taq Hot Start Version GMP Grade 43
Jan 25, 2016: Release of GMP grade PCR enzyme for genetic diagnosis 44
Other Significant Developments 45
Jun 06, 2016: WaferGen Bio-systems and Takara Bio Announce Exclusive Distribution Agreement for Japan 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
Takara Bio Inc, Medical Equipment, Key Facts, 2017 2
Takara Bio Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Takara Bio Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Takara Bio Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Takara Bio Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Takara Bio Inc, Deals By Market, 2011 to YTD 2017 9
Takara Bio Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Rubicon Genomics Raises USD2 Million in Venture Financing 12
Rubicon Genomics Enters Into Licensing Agreement With University Of Michigan 13
WaferGen Bio-systems Enters into Distribution Agreement with Takara Bio 14
Takara Bio Enters into Agreement with Integrated DNA Technologies 15
WaferGen Biosystems Enters into Research Agreement with Women's College Research Institute 16
Rubicon Genomics Enters Into Distribution Agreement With GenoMax Technologies For DNA Library Prep Kits 17
Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 18
WaferGen Biosystems Enters Into Co-Marketing Agreement With Qiagen 19
Takara Bio Enters Into Co-Marketing Agreement With Pathogenica For HAI Sequencing Service 20
WaferGen Biosystems Enters Into Agreement With Integrated DNA Technologies 21
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 22
Rubicon Genomics Enters Into Technology Integration Agreement With Kreatech Diagnostics 23
New England Biolabs Enters Into Co-Marketing Agreement With Rubicon Genomics 24
PerkinElmer Enters Into Distribution Agreement With Rubicon Genomics 25
Takara Bio Forms Joint Venture With DSS Imagetech 26
Takara Bio Enters Into Licensing Agreement With InVivoScribe Technologies For FLT3-ITD 27
Eppendorf Enters Into Licensing Agreement With Takara Bio 28
WaferGen Bio-systems Raises USD17.25 Million in Public Offering of Common Stock 29
Takara Bio Raises USD112 Million in Public Offering Of Common Stock 30
Takara Bio Acquires WaferGen Bio-Systems 31
Takara Bio Acquires Rubicon Genomics for USD75 Million 33
Takara Bio Inc, Key Competitors 34
Takara Bio Inc, Key Employees 35
Takara Bio Inc, Subsidiaries 36
Takara Bio Inc, Joint Venture 37